Biopole is a market-oriented and technology-driven innovative biopharmaceutical company. We are dedicated to research and develop advanced pharmaceutical excipients and raw materials, as well as formulation technologies. Our focus is to provide comprehensive and systematic solutions to our clients, empowering them to successfully expand globally.

Critical service point：

1. R&d innovation：The company has established a technological platform in the areas of advanced drug delivery technology and high-quality pharmaceutical raw materials. This includes expertise in asymmetric chiral synthesis, enzyme catalysis, fermentation, mRNA drug delivery technology, and transdermal absorption.
2. Globalization strategy：Utilizing technology to drive product exports and streamline registration processes, we have successfully expedited the entry of our products into international markets. Multiple products have been launched for registration in high-end markets in Europe and the United States, achieving commercial production smoothly through the use of outsourcing models.
3. Provide customized solution：Assist suppliers in enhancing product quality and market competitiveness. Offer clients market expansion consultation to aid them in identifying and exploring potential markets.